Picture EBD Group BIO-Europe Spring 2021 Digital 650x80
Organisation › Details

Biofidelity Ltd.

Biofidelity has developed an advanced molecular assay that is easily adopted and rapidly deployable for routine use in diagnostics labs around the world, without the need for investment in new instrumentation or infrastructure. With a simple workflow and fast time-to-result, the Company’s assays can transform the detection of genetic abnormalities within a sample by reliably detecting large panels of DNA mutations at extremely low frequencies. Biofidelity is focused on applications that will deliver the greatest improvements to patient outcomes, such as better targeted therapies for precision medicine and disease monitoring including early detection of pre-symptomatic disease, treatment resistance and disease recurrence. The Company is working with multiple international pharmaceutical and diagnostic companies, in addition to leading academics and clinicians, to apply the technology to fill important unmet clinical needs. Located in Cambridge, UK, Biofidelity is a private company founded in 2019 based on technology developed at Base4 Innovation. *


Period Start 2019-01-01 established
Product Industry molecular diagnostics
Persons Person Balmforth, Barnaby (Biofedility 201910 CEO + Co-Founder)
  Person 2 Frayling, Cameron (Lightcast Discovery 201902– CEO + Co-Founder before Base4 201307 CEO + founder)
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street 21 JJ Thomson Avenue
Broers Building
  City CB3 0FA Cambridge, Cambridgeshire
  Tel +44-1223-358652
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Biofidelity Ltd.. (10/10/19). "Press Release: Biofidelity Awarded Innovate UK Grant to Develop Non-Invasive Tests to Enable Precision Medicine". Cambridge.
Record changed: 2020-08-04


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Biofidelity Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe Spring 2021 Digital 650x80

» top